Partner Content Partner Content Hear from MedImmune and Ipsen at SMi’s Injectable Drug Deliv... Launch of Injectable Drug Delivery
Partner Content Partner Content Introducing the Launch of SMi’s Injectable Drug Delivery 201... Injectable Drug Delivery
News Sobi adds rare lymphoma drug with $580m Innate tie-up Sobi chief executive Guido Oelkers is preparing his exit, but is still cutting deals, licensing a lymphoma drug from Innate for up to $580m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
